Introduction {#S1}
============

With up to 300 million people affected worldwide, asthma is a global burden ([@B1]). It is one of the most common chronic diseases in the world, and the prevalence has increased significantly in Western countries in the last decades ([@B2]). The disease is characterized by airway hyperresponsiveness (AHR), eosinophilic airway inflammation, and excessive mucus secretion. This leads to shortness of breath, wheezing, coughing, and chest tightness in genetically susceptible individuals. Asthma can be triggered by a wide range of environmental stimuli, such as inhaled allergens \[e.g., house dust mite (HDM), animal dander\], respiratory infections, and airborne pollutants (e.g., tobacco smoke, air pollution) ([@B3]).

The remarkable increase in the prevalence of asthma and allergies in Western countries in recent decades is often explained by the loss of rural living conditions and associated changes in diet and lifestyle ([@B4]). This so-called hygiene hypothesis is supported by numerous epidemiological studies that consistently show that growing up on a farm reduces the risk of developing asthma and allergies ([@B5]--[@B8]). Farm-associated exposures contributing to this protective effect are contact with livestock, contact with animal feed, and the consumption of raw, unprocessed, cow's milk ([@B9]--[@B13]). The protective effect of raw cow's milk consumption is of particular interest since this was found to be independent of concomitant farm exposures and farm status ([@B10], [@B12], [@B13]). The latter suggests that non-farming populations might also benefit from the protective effects of raw cow's milk consumption.

Interestingly, cross-sectional evidence suggests that the asthma and allergy protective effects of raw cow's milk are abolished by milk processing ([@B9]). Processed cow's milk used for commercial purposes differs in many respects from raw cow's milk. Commercial milk is usually homogenized and heat treated to increase shelf life and to inactivate potentially pathogenic microorganisms ([@B14]). However, this milk processing also affects other milk components. The structure of the milk fat, for example, is changed remarkably by homogenization, and this might alter allergen presentation ([@B15]). In addition, heat-sensitive milk components such as proteins can be structurally altered upon heating and consequently lose functionality ([@B16]). These changes might (partly) explain why the beneficial farm milk effect seems to be lost after processing ([@B9]).

At the moment, raw milk can theoretically be considered as preventive treatment, but in reality, its consumption is limited due to its possible contamination with pathogens. To produce safe and protective milk, components and mechanisms underlying the asthma-protective effect need to be elucidated. At the same time, the current epidemiological evidence needs to be confirmed by causality. In the present study, we therefore examined the ability of raw cow's milk consumption to prevent the development of asthma in a murine HDM-induced asthma model. Because many differences between raw milk and commercial milk make it difficult to disentangle the different effects of milk processing, we compared raw and heated raw cow's milk to solely assess the effects of heating.

Materials and Methods {#S2}
=====================

Mice {#S2-1}
----

Six- to seven-week-old, specific pathogen-free, male BALB/c mice (*n* = 9/group) were purchased from Charles River Laboratories (The Netherlands) and housed at the animal facility of the Utrecht University under bio-contained sterile conditions using HEPA^®^ filtered isocages^®^ (Techniplast, Italy). Food and water were provided *ad libitum*. All animal procedures were conducted in accordance with the governmental guidelines and approved by the Ethical Committee for Animal Research of the Utrecht University, Utrecht, The Netherlands (DEC2014.III.12.117).

HDM-Induced Asthma Model {#S2-2}
------------------------

A schematic overview of the experimental design is shown in Figure [1](#F1){ref-type="fig"}. Anesthetized mice were intranasally (i.n.) sensitized with PBS or 1 µg HDM/40 μl PBS (Greer Laboratories, USA) on day 0 followed by an i.n. challenge with PBS or 10 µg HDM/40 μl PBS on days 7--11 ([@B17]). Three times a week throughout the study, starting 1 day before sensitization, mice were fed 0.5 mL raw cow's milk, heated raw cow's milk, or PBS by oral gavage. Raw cow's milk was collected from a biodynamic dairy farm (Hof Dannwisch, Germany). One day after collection, part of the raw milk was aliquoted and stored at −20°C until further use. The remainder was heated for 10 min at 80°C in a water bath, allowed to cool to room temperature, aliquoted, and then stored at −20°C until further use. Mice were killed on day 14.

![Schematic overview of the study design. Male BALB/c mice (*n* = 9/group) were sensitized intranasally (i.n.) with PBS or house dust mite (HDM) on day 0 and were challenged i.n. on days 7--11 with PBS or HDM. By oral gavage, the mice were given raw cow's milk, heated raw cow's milk, or PBS three times a week throughout the study, starting 1 day before sensitization. Mice were killed on day 14.](fimmu-08-01045-g001){#F1}

Airway Responsiveness {#S2-3}
---------------------

Mice were intraperitoneally (i.p.) anesthetized with a mixture of ketamine (Vetoquinol S.A., France; 125 mg/kg) and medetomidine (Pfizer, The Netherlands; 0.4 mg/kg). EMKA invasive measurement of dynamic resistance (EMKA Technologies, France) in response to increasing doses of methacholine (acetyl-β-methyl-choline chloride, Sigma-Aldrich, The Netherlands; 0--25 mg/mL, 10% puff for 10 s.) was used on day 14 to assess lung function. Average lung resistance (R~L~) is presented in cm H~2~O/(mL/sec) ([@B18]).

Bronchoalveolar Lavage {#S2-4}
----------------------

On day 14, mice were killed using an i.p. overdose of pentobarbital (Nembutal™, Ceva Santé Animale, The Netherlands; 600 mg/kg). Lungs were lavaged through a tracheal cannula with 1 mL of pyrogen-free saline (0.9% NaCl, 37°C) supplemented with protease inhibitor cocktail tablet (Complete Mini, Roche Diagnostics, Germany). This was followed by three lavages with 1 mL saline solution (0.9% NaCl, 37°C). The bronchoalveolar lavage fluid (BALF) was centrifuged (400 g, 5 min), and pellets of the four lavages were pooled. Total numbers of BALF cells were counted using a Bürker-Türk chamber (magnification 100×). For differential BALF cell counts, cytospin preparations were made and stained with Diff-Quick (Merz & Dade A.G., Switzerland). Numbers of eosinophils, neutrophils, lymphocytes, and macrophages were scored using light microscopy. At least 200 cells were counted, and the absolute number of each cell type was calculated ([@B19]).

Preparation of Lung Homogenates {#S2-5}
-------------------------------

Lung samples were homogenized in 1% Trition X-100 (Sigma-Aldrich)/PBS containing protease inhibitor (Complete Mini, Roche Diagnostics) using a Precellys 24 tissue homogenizer (Bertin Technologies, France). Homogenates were centrifuged (14.000 rpm, 10 min), and supernatants were collected and stored at −20°C until further use. Prior to cytokine and chemokine analysis, the protein concentration of each sample was determined by using the Pierce BCA protein assay kit standardized to bovine serum albumin (BSA) according to the manufacturer's protocol (Thermo Fisher Scientific, USA). Homogenates were subsequently diluted to a final concentration of 1 mg protein/mL.

*Ex Vivo* Lung Restimulation with HDM {#S2-6}
-------------------------------------

Single-lung cell suspensions were obtained by cutting lung samples into small pieces and by adding digestion buffer containing DNase I and Collagenase A (Roche Diagnostics) for 30 min. The digestion was stopped by adding fetal bovine serum (FBS; Bodinco, The Netherlands). Lung pieces were passed through a 70-µm nylon cell strainer and rinsed with 10 mL RPMI. Cells were washed and resuspended in RPMI 1640 culture medium (Lonza, USA) supplemented with 10% heat-inactivated FBS and 0.1% penicillin--streptomycin solution (Sigma-Aldrich). Lung cells (4 × 10^5^ cells/well) were cultured in medium with or without 50 µg/mL HDM. Supernatant was harvested after 4 days of culture (37°C, 5% CO~2~) and stored at −20°C until further analysis.

Measurement of Cytokines and Chemokines {#S2-7}
---------------------------------------

IL-33, CCL20, CCL17, and CCL22 concentrations were measured in lung homogenates with a DuoSet ELISA (R&D Systems, USA) and IL-5 and IL-13 with a Ready-SET-Go!^®^ ELISA (eBioscience, USA). A standard IL-13 flex set or a standard Th1/Th2/Th17 assay (BD Biosciences, The Netherlands) was used to determine cytokine concentrations in supernatants of lung restimulation. All assays were performed according to the manufacturer's protocol. The concentrations of cytokines and chemokines were expressed as picogram per milligram protein in lung homogenates and picogram per milliliter in lung restimulation supernatants.

Flow Cytometric Analysis of Immune Cells in the Lung {#S2-8}
----------------------------------------------------

Single-lung cell suspensions were resuspended in PBS/1% BSA (Sigma-Aldrich) and incubated for 15 min at 4°C with Fc block CD16/CD32 antibodies (BD Biosciences; 5 µg/mL) to prevent non-antigen-specific binding. Cells were subsequently stained with antibodies (eBioscience, The Netherlands, unless otherwise stated) against CD4-PerCP Cy5.5, GATA3-PE, Tbet-eFluor^®^ 660, RORγt-PE, CD25-Alexa Fluor^®^ 488, FoxP3-APC, CD11c-PerCP Cy5.5, MHCII-PE Cy7, CD11b-PE, and Fixable Viability Dye-eFluor^®^ 780 or matching isotype controls for 30 min at 4°C. Cells were fixed using fixation buffer (eBioscience) or permeabilized for intracellular staining using the FoxP3 staining buffer set (eBioscience) according to the manufacturer's protocol. Flow cytometry was performed using FACS Canto II (BD Biosciences), and results were analyzed using Flowlogic Software (Inivai Technologies, Australia). To distinguish between negative and positive staining cell populations, fluorescence minus one controls were used (after the exclusion of debris, doublets and non-viable cells).

Statistical Analysis {#S2-9}
--------------------

Data are presented as mean ± SEM and were analyzed using one- or two-way ANOVA, followed by Bonferroni's multiple comparisons test. As pulmonary IL-5 concentrations did not obtain normality, data were analyzed using Kruskal--Wallis test followed by Dunn's multiple comparisons test. Results were considered statistically significant when *P* \< 0.05. Analyses were performed using GraphPad Prism software (version 6.07).

Results {#S3}
=======

Raw Milk Prevents HDM-Induced AHR and Pulmonary Inflammation {#S3-1}
------------------------------------------------------------

To assess the effects of raw and heated raw milk on lung function, AHR was measured in response to increasing doses of methacholine. Baseline airway responsiveness tended to be higher in HDM-mice compared to PBS-mice. An increase in AHR was observed in HDM-mice compared to PBS-mice after methacholine exposure. Although intervention with heated raw milk showed no significant effect, increased AHR was prevented by intervention with raw milk (Figure [2](#F2){ref-type="fig"}A). To study the extent of pulmonary inflammation, BALF was examined. The total number of inflammatory cells in the BALF of HDM-mice was significantly higher than in PBS-mice (Figure [2](#F2){ref-type="fig"}B). This was mainly due to an increase in the number of eosinophils (Figure [2](#F2){ref-type="fig"}C), although numbers of lymphocytes, neutrophils, and macrophages were increased as well (Figures [2](#F2){ref-type="fig"}D--F). Raw milk reduced the total number of inflammatory cells in the BALF, which was reflected by lower numbers of eosinophils, lymphocytes, neutrophils, and macrophages (Figures [2](#F2){ref-type="fig"}B--F). Pulmonary inflammation was unaffected by heated raw milk (Figures [2](#F2){ref-type="fig"}B--F).

![House dust mite (HDM)-induced airway hyperresponsiveness and pulmonary inflammation were prevented by raw milk. **(A)** Lung resistance (R~L~) measured after exposure to increasing doses of methacholine. **(B--E)** Differential bronchoalveolar lavage fluid (BALF) cell counts. **(B)** Total BALF cells, **(C)** absolute number of eosinophils, **(D)** lymphocytes, **(E)** neutrophils, and **(F)** macrophages. Data are presented as mean ± SEM. (**A**) *n* = 7--9 mice/group. \**P* \< 0.05, \*\**P* \< 0.01 compared to PBS-PBS group, ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01 compared to HDM-HDM group as analyzed with one-way ANOVA followed by Bonferroni's multiple comparisons test. (**B--E**) *n* = 8--9 mice/group. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001 as analyzed with one-way ANOVA followed by Bonferroni's multiple comparisons test. Contr, mice treated with PBS.](fimmu-08-01045-g002){#F2}

Raw Milk Suppresses the Frequency of Conventional Dendritic Cells (cDCs) and Related CCL17 Concentrations in the Lung {#S3-2}
---------------------------------------------------------------------------------------------------------------------

To determine the effect of raw and heated raw milk on pulmonary cytokines and chemokines, we analyzed supernatants of lung homogenates. IL-33, CCL20, CCL17, and CCL22 concentrations were increased in HDM-mice compared to PBS-mice (Figures [3](#F3){ref-type="fig"}A--D). Neither raw nor heated raw milk were able to affect the concentrations of IL-33, CCL20, and CCL22 (Figures [3](#F3){ref-type="fig"}A,B,D), but both significantly reduced the concentration of CCL17 (Figure [3](#F3){ref-type="fig"}C). Since CCL17 is mainly secreted by CD11b^+^ cDCs, this DC subtype was analyzed in lung cell suspensions. A higher percentage of CD11b^+^ cDCs was observed in HDM-mice compared to PBS-mice (Figure [3](#F3){ref-type="fig"}E). While heated raw milk showed no effect on this increase, it was reduced by raw milk (Figure [3](#F3){ref-type="fig"}E).

![Frequency of CD11b^+^ conventional dendritic cells (cDCs) and related CCL17 concentrations in the lung were decreased after exposure to raw milk. Levels of epithelial- and DC-derived Th2-polarizing mediators in the lung. **(A)** IL-33, **(B)** CCL20, **(C)** CCL17, and **(D)** CCL22 concentrations were measured in supernatant of lung homogenates (picogram per milligram protein). **(E)** The percentage of CD11b^+^ cDCs (MHCII^+^ of CD11c^+^CD11b^+^ cells) was analyzed in lung cell suspensions. Data are presented as mean ± SEM, *n* = 8--9 mice/group. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\*\**P* \< 0.0001 as analyzed with one-way ANOVA followed by Bonferroni's multiple comparisons test. Contr, mice treated with PBS.](fimmu-08-01045-g003){#F3}

Percentage of Th2 and Th17 Cells in the Lung Decreases after Exposure to Raw Milk {#S3-3}
---------------------------------------------------------------------------------

Lung cell suspensions were analyzed for T cell subsets. The frequency of Th2, Th17, and regulatory T cells (Tregs) was higher in HDM-mice than in PBS-mice (Figures [4](#F4){ref-type="fig"}A,B,D). In line with the reduced concentration of the Th2 attracting chemokine CCL17, the frequency of Th2 cells in the lung was reduced by both raw and heated raw milk (Figure [4](#F4){ref-type="fig"}A). For Th17 cells, a similar effect was observed (Figure [4](#F4){ref-type="fig"}B), while neither milk type affected the percentage of Treg cells (Figure [4](#F4){ref-type="fig"}D). Th1 cells were not increased in HDM-mice compared to PBS-mice and showed no raw milk effect (Figure [4](#F4){ref-type="fig"}C). However, heated raw milk, did reduce the percentage of Th1 cells (Figure [4](#F4){ref-type="fig"}C).

![Raw milk suppressed the frequency of Th2 and Th17 cells in the lung. Lung T cell subsets. **(A)** The percentage of Th2 cells (GATA3^+^ of CD4^+^ cells), **(B)** Th17 cells (RORγ^+^ of CD4^+^ cells), **(C)** Th1 cells (Tbet^+^ of CD4^+^ cells), and **(D)** regulatory T cells (Tregs) (CD25^+^FoxP3^+^ of CD4^+^ cells) was analyzed in lung cell suspensions. Data are presented as mean ± SEM, *n* = 8--9 mice/group. \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001 as analyzed with one-way ANOVA followed by Bonferroni's multiple comparisons test. Contr, mice treated with PBS.](fimmu-08-01045-g004){#F4}

Raw Milk Reduces IL-4 and IL-13 Production after *Ex Vivo* Restimulation of Lung T Cells with HDM {#S3-4}
-------------------------------------------------------------------------------------------------

To investigate whether the reduction in Th2 and Th17 cell frequency by raw and heated raw milk also affected the production of Th2 and Th17 related cytokines, we measured allergen-specific IL-4, IL-13, and IL-17A secretion in supernatants of lung cell suspensions after *ex vivo* restimulation with HDM. No cytokine production was observed in PBS-mice, whereas HDM-mice showed a significant, HDM-specific, increase in IL-4 and IL-13 (Figures [5](#F5){ref-type="fig"}A,B). Raw milk and heated raw milk reduced the IL-4 and IL-13 concentrations (Figures [5](#F5){ref-type="fig"}A,B). Although IL-17A concentrations were increased in HDM-mice compared to PBS-mice, neither raw nor heated raw milk showed any effect (data not shown).

![IL-4 and IL-13 production after *ex vivo* restimulation with house dust mite (HDM) was inhibited by raw milk. Lung cell suspensions were *ex vivo* restimulated with medium or HDM for 4 days (37°C, 5% CO~2~). **(A)** IL-4 (treatment: *P* \< 0.01, restimulation: *P* \< 0.001, interaction: *P* \< 0.01) and **(B)** IL-13 (treatment: *P* \< 0.01, restimulation: *P* \< 0.001, interaction: *P* \< 0.01) concentrations were measured in the supernatants (picogram per milliliter). Data are presented as mean ± SEM, *n* = 7--9 mice/group. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\*\**P* \< 0.0001 as analyzed with two-way ANOVA followed by Bonferroni's multiple comparisons test.](fimmu-08-01045-g005){#F5}

Inhibition of Pulmonary IL-5 and IL-13 Concentrations by Raw Milk {#S3-5}
-----------------------------------------------------------------

Supernatants of lung homogenates were furthermore analyzed to investigate whether raw or heated raw milk also reduced local concentrations of type 2 cytokines. IL-5 concentrations did not differ between HDM-mice and PBS-mice, but IL-13 concentrations were increased (Figures [6](#F6){ref-type="fig"}A,B). This increase in IL-13 was reduced by raw milk (Figure [6](#F6){ref-type="fig"}B), which also seemed to suppress IL-5 concentrations (Figure [6](#F6){ref-type="fig"}A). No reduction in local IL-5 or IL-13 concentrations was observed when mice received heated raw milk (Figures [6](#F6){ref-type="fig"}A,B).

![Raw milk reduced pulmonary IL-5 and IL-13 concentrations. Type 2 cytokine concentrations in the lung. **(A)** IL-5 and **(B)** IL-13 concentrations were measured in the supernatant of lung homogenates (picogram per milligram protein). Data are presented as mean ± SEM, *n* = 7--9 mice/group. \**P* \< 0.05, \*\**P* \< 0.01 as analyzed with Kruskal--Wallis test followed by Dunn's multiple comparisons test (IL-5) or one-way ANOVA followed by Bonferroni's multiple comparisons test (IL-13). Contr, mice treated with PBS.](fimmu-08-01045-g006){#F6}

Discussion {#S4}
==========

In the present study, we demonstrated that raw cow's milk consumption prevented the development of asthma in a murine HDM-induced allergic asthma model. Strong protective effects on AHR and airway inflammation were observed which coincided with a reduced type 2 immune response. Heat-treated raw milk showed no asthma-protective effect.

Large-scale epidemiological studies in European populations have consistently shown that growing up on a traditional farm protects against the development of asthma ([@B5]--[@B8]). These studies invested a lot of effort to determine farm-related exposures contributing to this protective effect. Raw cow's milk consumption is one of the factors repeatedly shown to be protective ([@B9]--[@B13]). However, all current evidence showing a relationship between raw cow's milk consumption and the prevention of asthma is based on observed associations that do not confirm a causal relationship. To investigate causality, we used a murine HDM-induced allergic asthma model. This model mimics hallmark features of allergic asthma in humans and has clinical relevance due to the use of HDM as aeroallergen ([@B20], [@B21]).

As our data show, and in accordance with existing epidemiological studies, raw cow's milk prevents the development of allergic asthma. Raw milk prevented HDM-induced AHR and abrogated pulmonary inflammation. This protective effect was abolished after heating the milk, which suggests that heat-sensitive milk components play a role in the asthma-protective effect of raw milk. The observed contribution of heat-sensitive components is in line with observations from the GABRIELA study, a large epidemiological study in which an inverse association between the whey fraction of the milk and asthma was found ([@B9]). Whey proteins such as α-lactalbumin, β-lactoglobulin, lactoferrin, immunoglobulins, and TGF-β are heat-sensitive and are known to have immunomodulatory effects ([@B22], [@B23]). Follow-up studies with these milk components need to demonstrate whether they also play a role in our model. Another constituent, previously found to be associated with a reduced asthma risk, is the fat content of raw milk ([@B24]). Since this fat content is unaffected by heat, it could be responsible for the slight reduction we observed in AHR by mice consuming heated raw milk (0.78 mg/mL of methacholine). However, for the moment, we can only speculate that the fat content in combination with heat-sensitive components is responsible for the asthma-protective effect of raw milk in our study.

To determine how raw milk exerts its effect, we looked at several inflammatory mediators involved in the pathogenesis of allergic asthma. Allergic asthma is generally induced by HDM allergens, and a key trigger in the recognition of HDM is the activation of epithelial cells ([@B25]). Epithelial cells are activated when HDM allergens bind to pattern recognition receptors (PRRs), such as TLR4, on their cell membrane. On activation, they produce chemokines and cytokines that attract DCs to the lung and instruct them to induce Th2 immunity ([@B26]). Since DCs also express PRRs themselves, they can also be directly activated by HDM allergens ([@B1]). Epithelial- (IL-33 and CCL20) and DC-derived (CCL17 and CCL22) mediators were indeed increased after HDM exposure in our model, and the frequency of CD11b^+^ cDCs was also elevated. These results are in line with human studies showing that IL-33, CCL20, CCL17, and CCL22 levels, as well as DC numbers, are elevated in the airways of asthmatic patients compared to healthy controls ([@B27]--[@B30]). Raw milk did not affect the epithelial mediators but did reduce the percentage of CD11b^+^ cDCs and the concentration of CCL17. The CD11b^+^ cDC subpopulation plays an important role in inducing allergic inflammation via the secretion of CCL17 and CCL22 ([@B31]). Both of these chemokines are CCR4 ligands and will attract CCR4-expressing Th2 cells to the lungs, which is essential for the development of allergic asthma ([@B32]). The importance of CCL17 and CCL22 is furthermore confirmed in murine asthma models where their neutralization with specific antibodies resulted in attenuation of AHR and airway inflammation ([@B33], [@B34]).

The reduction in the CD11b^+^ cDC-derived CCL17 concentration by raw milk may have resulted in a reduced Th2 cell influx. Indeed, the frequency of GATA3^+^CD4^+^Th2 cells in the lung was decreased by raw milk. GATA3 expression is known to be markedly increased in T cells derived from the airways of asthmatic patients compared to healthy individuals ([@B35]). It is essential not only for the differentiation of naïve T cells into Th2 cells but also for the secretion of Th2-related cytokines (IL-4, IL-5, and IL-13) ([@B36], [@B37]). In addition to reducing Th2 cell frequency, raw milk also reduced the percentage of Th17 cells in the lung, which mainly recruit and activate neutrophils and are known to be increased in asthmatic patients ([@B38]). This reduction in Th17 cells indeed coincided with a reduced neutrophil influx to the lung. While the exact contribution of Th17 cells in allergic asthma remains to be elucidated, blocking Th17 immunity as a therapy is gaining interest ([@B39], [@B40]). The reduction of Th2 and Th17 cells by raw milk was not accompanied by a shift toward a more Th1 or Treg immune response.

In accordance with the reduced Th2 cell influx, raw milk also reduced concentrations of Th2 related cytokines. IL-4 and IL-13 production was suppressed after *ex vivo* restimulation of lung T cells with HDM. In addition, local pulmonary IL-13 concentrations were inhibited and a similar pattern was observed for IL-5 (Figure [7](#F7){ref-type="fig"}). Together, these type 2 cytokines are responsible for the salient features of allergic asthma ([@B3], [@B41]).

![Schematic overview of the effects of raw and heated raw milk on allergic asthma. Following exposure to house dust mite (HDM), lung epithelial cells produce chemokines, like CCL20, that attract immature preconventional dendritic cells (cDCs) to the lung, and cytokines, like IL-33, that activate CD11b^+^ cDCs. Concentrations of these epithelial-derived mediators in the lung were unaffected by raw and heated raw milk. Activated lung CD11b^+^ cDCs subsequently migrate to the mediastinal lymph nodes where they differentiate naïve T cells into Th2 cells. These Th2 cells migrate back to the lung mucosal tissue in response to CCL17 and CCL22 produced by poorly migratory DCs. Lung CCL17 concentration, as well as lung Th2 cell frequency, was reduced by both milk types. On subsequent HDM challenges, Th2 cells will start to produce IL-4, IL-5, and IL-13. The concentration of these Th2-related cytokines was also suppressed by both milk types after *ex vivo* restimulation of lung T cells with HDM. However, pulmonary concentrations of these cytokines, measured in lung homogenates, were only reduced by raw milk. Since not only Th2 cells but also ILC2 cells, mast cells, basophils, and eosinophils can produce these type 2 cytokines, it suggests that only raw milk affects these other cells types. Eventually, only raw milk prevented airway hyperresponsiveness and pulmonary inflammation indicating the importance of reduced local type 2 cytokine levels.](fimmu-08-01045-g007){#F7}

In contrast to raw milk, heated raw milk was not able to prevent the development of asthma. Even though it reduced pulmonary CCL17 concentrations, the frequency of Th2 and Th17 cells in the lung, and the IL-4 and IL-13 production by lung T cells after *ex vivo* restimulation with HDM, which is potentially beneficial in allergic diseases, this did not result in reduced airway inflammation in our study. Heated raw milk did not affect local pulmonary IL-5 and IL-13 concentrations. This discrepancy in the effects on type 2 cytokines might be explained by the fact that local levels can also be produced by immune cells other than T cells. It is well known that type 2 cytokines are produced not only by Th2 cells but also by ILC2 cells, eosinophils, basophils, and mast cells ([@B42]). Since raw milk suppressed local type 2 cytokine levels, this implies that a reduction in locally produced IL-5 and IL-13 is essential to the preventive effects of raw milk. Furthermore, it suggests that only raw milk affects these other cells types, but this needs to be confirmed in future studies (Figure [7](#F7){ref-type="fig"}).

The promising results of this study suggest that there is a causal relationship between raw cow's milk consumption and the prevention of allergic asthma. The protective effect seems to start as early as the DC level, where mediators priming Th2 immunity were suppressed. However, suppression of local type 2 cytokine levels seems to be crucial. This study supports current epidemiological findings and emphasizes the need for minimally processed, safe milk. By comparing raw and heated raw milk, a first attempt was made to pinpoint the milk components underlying the asthma-protective effect of raw milk. Heat-sensitive milk components were found to be responsible. However, future research should aim at elucidating the specific heat-sensitive milk components involved and their underlying mechanism.
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